These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 11435541

  • 1. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion.
    Kamada K, Nakanishi T, Kitamoto M, Aikata H, Kawakami Y, Ito K, Asahara T, Kajiyama G.
    J Vasc Interv Radiol; 2001 Jul; 12(7):847-54. PubMed ID: 11435541
    [Abstract] [Full Text] [Related]

  • 2. Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma.
    Ono Y, Yoshimasu T, Ashikaga R, Inoue M, Shindou H, Fuji K, Araki Y, Nishimura Y.
    Am J Clin Oncol; 2000 Dec; 23(6):564-8. PubMed ID: 11202797
    [Abstract] [Full Text] [Related]

  • 3. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
    Ueno K, Miyazono N, Inoue H, Nishida H, Kanetsuki I, Nakajo M.
    Cancer; 2000 Apr 01; 88(7):1574-81. PubMed ID: 10738215
    [Abstract] [Full Text] [Related]

  • 4. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.
    Chen MS, Li JQ, Zhang YQ, Lu LX, Zhang WZ, Yuan YF, Guo YP, Lin XJ, Li GH.
    World J Gastroenterol; 2002 Feb 01; 8(1):74-8. PubMed ID: 11833075
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
    Maeda S, Shibata J, Fujiyama S, Tanaka M, Noumaru S, Sato K, Tomita K.
    Hepatogastroenterology; 2003 Feb 01; 50(51):809-13. PubMed ID: 12828090
    [Abstract] [Full Text] [Related]

  • 8. [Efficacy and toxicity of transcatheter arterial chemoembolization with Cisplatin suspended in lipiodol for unresectable hepatocellular carcinoma].
    Uyama N, Hatano E, Maetani Y, Isoda H, Shibata T, Taura K, Oe S, Naito M, Yasuchika K, Fujii H, Ikai I, Uemoto S.
    Gan To Kagaku Ryoho; 2008 May 01; 35(5):775-80. PubMed ID: 18487912
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hypersensitivity reactions to transcatheter chemoembolization with cisplatin and Lipiodol suspension for unresectable hepatocellular carcinoma.
    Kawaoka T, Aikata H, Katamura Y, Takaki S, Waki K, Hiramatsu A, Takahashi S, Hieda M, Kakizawa H, Chayama K.
    J Vasc Interv Radiol; 2010 Aug 01; 21(8):1219-25. PubMed ID: 20619676
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.
    Mabed M, Esmaeel M, El-Khodary T, Awad M, Amer T.
    Eur J Cancer Care (Engl); 2009 Sep 01; 18(5):492-9. PubMed ID: 19453695
    [Abstract] [Full Text] [Related]

  • 14. Transcatheter arterial chemoembolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma.
    Kasai K, Ushio A, Sawara K, Miyamoto Y, Kasai Y, Oikawa K, Kuroda H, Takikawa Y, Suzuki K.
    World J Gastroenterol; 2010 Jul 21; 16(27):3437-44. PubMed ID: 20632449
    [Abstract] [Full Text] [Related]

  • 15. Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization.
    Chia-Hsien Cheng J, Chuang VP, Cheng SH, Lin YM, Cheng TI, Yang PS, Jian JJ, You DL, Horng CF, Huang AT.
    Int J Cancer; 2001 Aug 20; 96(4):243-52. PubMed ID: 11474499
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Volumetric and morphological CT parameters for assessing prognosis and treatment control in hepatocellular carcinoma undergoing arterial chemoembolization].
    Vogl TJ, Trapp M, Pegios W, Mack M, Bechstein WO, Keck W, Scholz A, Schröder H, Neuhaus P, Felix R.
    Rofo; 1997 Sep 20; 167(3):219-26. PubMed ID: 9376548
    [Abstract] [Full Text] [Related]

  • 20. Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and gelfoam.
    Ngan H, Lai CL, Fan ST, Lai EC, Yuen WK, Tso WK.
    Clin Radiol; 1993 May 20; 47(5):315-20. PubMed ID: 8389682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.